Natural history of HSV1 and HSV2 infection. Asymptomatic viral excretion. Mother-infant transmission. Indirect transmission;Histoire naturelle de l'infection à herpès simplex de type 1 et 2. Excrétion virale asymptomatique. Transmission mère-enfant. Transmission indirecte

Annales de Dermatologie et de Venereologie

Volumn 129, Issue 4 II, 2002, Pages 577-585

  Morand, P ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

CONFERENCE PAPER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPETENCE; NEWBORN INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; RECURRENT INFECTION; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS CULTURE; VIRUS EXCRETION; VIRUS SHEDDING;

DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL DISEASES; FRANCE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT, NEWBORN; PATIENT EDUCATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; VIRUS SHEDDING;

EID: 0036273769     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Herpes simplex virus infections
2. Genital herpes-how much of a public-health problem?
3. Herpes simplex virus: The importance of asymptomatic shedding
4. Herpes simplex viruses
5. Prospects for control of herpes simplex virus disease through immunization
6. A prospective study of new infections with herpes simplex virus type 1 and type 2
7. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time
8. The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks
9. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type
10. Evidence of latency and reactivation of both herpes simplex virus HSV1 and HSV2 in the genital region
11. Daily stress and recurrence of genital herpes simplex
12. Virologic characteristics of subclinical and symptomatic genital herpes infections
13. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons
14. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment
15. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men
16. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial
17. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women
18. Herpes simplex virus shedding and plasma human immunodeficiency virus rna levels in coinfected women
19. Oral shedding of herpes simplex virus type 1: A review
20. Shedding of herpes simplex virus type 1 in to saliva
21. Lack of oral HSV2 in a college student population
22. Detection of herpes simplex virus (HSV) in the saliva from 1,000 oral surgery out patients by the polymerase chain reaction (PCR) and virus isolation
23. Correlation between detection of herpes simplex virus in oral secretions by PCR and susceptibility to experimental UV radiation-induced herpes labialis
24. The management of herpes simplex virus infection in pregnancy
25. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995
26. Neonatal herpes in Denmark 1977-1991
27. Neonatal Herpes Simplex Virus Infection in Relation to Asymptomatic Maternal Infection at the Time of Labor
28. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus
29. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections
30. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery
31. Asymptomatic shedding of herpesvirus during labor
32. The acquisition of herpes simplex virus during pregnancy
33. A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy
34. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women
35. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy
36. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1
37. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: Effects of hormonal contraception, pregnancy, and vitamin A deficiency
38. Acyclovir in late pregnancy to prevent neonatal herpes simplex
39. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding
40. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection
41. Oral acyclovir and recurrent genital herpes during late pregnancy
42. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes
43. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: An open-label trial
44. New therapies and prevention strategies for genital herpes
45. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women
46. Intrauterine herpes simplex virus infection
47. Intrauterine herpes simplex virus infection
48. Intrauterine herpes simplex virus infections
49. Herpes simplex virus DNA in amniotic fluid without neonatal infection
50. Transmission of herpes-simplex virus type 1 in a nursery for the newborn. Identification of viral isolates by D.N.A. "fingerprinting"
51. An outbreak of herpes simplex virus type 1 in an intensive care nursery
52. Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns
53. Detection of herpes simplex virus DNA in maternal breast milk by in situ hybridization with tyramide signal amplification
54. Neonatal herpes simplex infection possibly acquired via maternal breast milk
55. Transmission of herpes simplex virus type 1 to a newborn infant during endotracheal suctioning for meconium aspiration
56. Risk of fetal infection from invasive procedures
57. Nosocomial spread of viral disease
58. Primary herpes labialis acquired during scuba diving course
59. Survival of herpes simplex virus in water specimens collected from hot tubs in spa facilities and on plastic surfaces
60. Shedding and survival of herpes simplex virus from "fever blisters"
61. Survival of herpes simplex virus type 1 on some frequently touched objects in the home and public buildings
62. Studies on the survival and inactivation of herpes simplex virus type 1 on coins
63. Fomites and herpes simplex virus